Tuesday, 20 Mar 2018

You are here

Kidney transplant improves survival in GPA

Even with currently available treatment modalities, ESRD is a common complication of Granulomatosis with polyangiitis (GPA) occurring in approximately 25% of patients. Transplantation frequently used for ESRD but has not been applied widely in GPA.

Current analysis is aimed at evaluation of benefits of transplantation in extending surgical or prisons with GPA comparing to remaining on waiting list.

1,556 patients with ESRD due to GPA who were registered in the United States Renal Data System (USRDS) and were waitlisted for a renal transplant between 1995 and 2015 were included in this analysis and adjusted for sociodemographic covariates (e.g., age, gender) as well as comorbidities (e.g., diabetes, cardiovascular disease (CVD). 977 (63%) of these patients received a transplant. The majority were male (60%) and white (84%).

In fully-adjusted analyses, transplanted patients had a 59% lower risk of death compared to those who remained on the waitlist (RR 0.41, 95% CI 0.34-0.49).   


Specifically, study reports lower risk of death from CVD (HR 0.06, 95% CI 0.03-0.1) and infection (HR 0.3 95% CI 0.2-0.6). There was no difference in the risk of cause-specific death from cancer (HR 0.5 95% CI 0.2-1.2). The study emphasizes the need to identify obstacles to transplantation in patient with EXRD due to GPA. Additionally, modalities aimed at reducing the risk of CVD and infection in patients on the waitlist would likely improve survival.

Add new comment

More Like This

MMWR: Arthritis Prevalence Increases and Varies Widely

MMWR reports that In 2015, the number of adults with arthritis continued to increase; with marked geographic variability in arthritis estimates with gaps in arthritis management.

The CDC estimates that physician-diagnosed arthritis affects 54 million of adults in the United States with an annual cost of approximately $300 billion annually.

The RheumNow Week in Review - 16 March 2018

Dr. Jack Cush reviews the highlights from the news, journals and major meetings. Bigtime rheumatologic lessons with tales from intestinal crypts, the friendly skies & the hips of hockey players. Also the microbiome and lupus, benefits of ENT findings with GPA and rare risk of opportunistic infections with biologics.

The RheumNow Week in Review - 9 March 2018

Dr. Jack Cush reviews highlights, news and recent research published this past week on RheumNow.com. This week's report includes news on new regulatory changes, new indication for tofacitinib, the rise and deficits of opioids and the benefits of fish and bariatric surgery.

ACR Responds to Association Health Plans Proposed Rule

In comments submitted today to the US Department of Labor in response to its Association Health Plans (AHP) proposed rule, the American College of Rheumatology urged Administration officials to protect essential health benefits and other consumer protections that make it possible for individuals living with rheumatic diseases to access comprehensive and affordable healthcare.

The RheumNow Week in Review - 2 March 2018

Dr. Jack Cush reviews the news and highlights from the past week on RheumNow.com.